Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.
Dominic BettingerEleni GkikaMichael SchultheissNicolas GlaserSophie LangeLars MaruschkeNico BuettnerSimon KirsteUrsula NestleAnca-Ligia GrosuRobert ThimmeThomas B BrunnerPublished in: BMC cancer (2018)
SBRT after prior HCC therapy in selected patients shows comparable LC at 1 year, OS and 1-year mortality compared to patients treated with TACE.